HDI Highlighter, The First Intelligent Tool to Screen the Literature on Herb–Drug Interactions Anthony CnuddePatrick WatrinFlorence Souard Review Article 31 May 2022 Pages: 761 - 788
A Review of Population Pharmacokinetic Analyses of Linezolid Enrique Bandín-VilarLaura García-QuintanillaAnxo Fernández-Ferreiro Review Article 14 June 2022 Pages: 789 - 817
Filgotinib: A Clinical Pharmacology Review Florence NamourKacey AndersonChantal Tasset Review Article Open access 31 May 2022 Pages: 819 - 832
Population Pharmacokinetics of Cotadutide in Subjects with Type 2 Diabetes Ye GuanNeang LyRosalinda H. Arends Original Research Article 02 March 2022 Pages: 833 - 845
Population Pharmacokinetics and Dosing Simulations of Ceftriaxone in Critically Ill Patients Receiving Extracorporeal Membrane Oxygenation (An ASAP ECMO Study) Vesa ChengMohd H. Abdul-AzizASAP ECMO Investigators Original Research Article Open access 06 March 2022 Pages: 847 - 856
Single-Dose Pharmacokinetics of Milvexian in Participants with Mild or Moderate Hepatic Impairment Compared with Healthy Participants Vidya PereraGrigor AbelianBindu Murthy Original Research Article Open access 09 March 2022 Pages: 857 - 867
Pooled Population Pharmacokinetic Analysis for Exploring Ciprofloxacin Pharmacokinetic Variability in Intensive Care Patients Tingjie GuoAlan Abdullathe Dutch Antibiotic PK/PD Collaborators Original Research Article Open access 09 March 2022 Pages: 869 - 879
Population Pharmacokinetics of Rivaroxaban in Chinese Patients with Non-Valvular Atrial Fibrillation: A Prospective Multicenter Study Feilong ZhangXuehai ChenJinhua Zhang Original Research Article 22 March 2022 Pages: 881 - 893
Using a Validated Population Pharmacokinetic Model for Dosing Recommendations of Continuous Infusion Piperacillin for Critically Ill Adult Patients Ibrahim El-HaffafRomain GuilhaumouAmélie Marsot Original Research Article 28 March 2022 Pages: 895 - 906
An Integral Pharmacokinetic Analysis of Piperacillin and Tazobactam in Plasma and Urine in Critically Ill Patients Eveline WallenburgRob ter HeineRoger J. M. Brüggemann Original Research Article Open access 04 April 2022 Pages: 907 - 918
Correction to: Pharmacokinetic and Pharmacodynamic Properties of Cemdisiran, an RNAi Therapeutic Targeting Complement Component 5, in Healthy Subjects and Patients with Paroxysmal Nocturnal Hemoglobinuria Prajakta BadriXuemin JiangGabriel J. Robbie Correction Open access 17 May 2022 Pages: 919 - 919